Results 71 to 80 of about 179,953 (145)
ABSTRACT Introduction Sinonasal cancers are rare and heterogeneous and pose a therapeutic challenge at an advanced stage due to the lack of data on appropriate systemic management. Methods This retrospective multicenter study analyzed 83 patients with recurrent or metastatic sinonasal carcinomas ineligible for curative treatment, treated in France ...
Marie Degrange +16 more
wiley +1 more source
Mitotic index is (still) important for grading isocitrate dehydrogenase (IDH)-mutant astrocytoma. [PDF]
Roberts KF, Dahiya SM.
europepmc +1 more source
Single‐cell and spatial transcriptomic profiling of 69 adult‐type diffuse gliomas revealed seven recurrent malignant cell states. GBMs were enriched for astrocyte‐like progenitor, hypoxic, and proliferative states, with higher T‐ and myeloid‐cell infiltration but transcriptional immune suppression.
Ashraf Zaman +14 more
wiley +1 more source
Spin‐ and‐gradient‐echo DSC MRI at 7 T allows for characterization of the microvasculature at an improved resolution and a reduced gadolinium‐based contrast agent dosage while maintaining increased vascular contrast. Ratios between normal‐appearing gray matter and white matter for relative cerebral blood volume and vessel size estimates were similar ...
Karen N. van der Werff +12 more
wiley +1 more source
ABSTRACT Aim Leptoceridae is the second most diverse caddisfly family, spreading across all biogeographical regions but with a higher species richness in the Oriental region; nevertheless, the Afrotropical, Austral and Neotropical regions have greater genera diversity and endemicity.
Everton S. Dias +3 more
wiley +1 more source
Isocitrate dehydrogenase mutations in myeloid malignancies
Alterations to genes involved in cellular metabolism and epigenetic regulation are implicated in the pathogenesis of myeloid malignancies. Recurring mutations in isocitrate dehydrogenase (IDH) genes are detected in approximately 20% of adult patients ...
S M Chan +11 more
core +1 more source
Optimize treatment approaches in isocitrate dehydrogenase (IDH) mutant gliomas: open issues. [PDF]
Rudà R.
europepmc +1 more source
Naturopathic Treatment of Grade III Oligodendroglioma With Progression to Grade IV Isocitrate Dehydrogenase (IDH)-Mutant Astrocytoma and the Development of Spinal Gliomatosis. [PDF]
Terrani KF, Reynolds CD, Rogers SN.
europepmc +1 more source
Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1. [PDF]
Cordner R +14 more
europepmc +1 more source
Radiological Prediction of Isocitrate Dehydrogenase (IDH) Mutational Status and Pathological Verification for Lower-Grade Astrocytomas. [PDF]
Yano H +9 more
europepmc +1 more source

